Directory
>
Michael Kallelis
Michael Kallelis
Chief Executive Officer | Mikart, LLC
Atlanta, Georgia, United States
Michael Kallelis
Summary
Michael Kallelis is an accomplished Chief Executive Officer with a robust background in biochemistry and biotechnology, specializing in growth strategies for various market segments including drug development and diagnostics. With over 25 years of experience, he has successfully led organizations from start-ups to Fortune 6 companies, demonstrating a strong ability to manage and motivate cross-functional teams towards achieving common business goals. His expertise extends to mergers and acquisitions, sales, marketing, and operations, with a proven track record of increasing revenues and operational efficiencies. Michael's leadership is characterized by his strategic vision and hands-on approach, which has resulted in significant growth and innovation within the companies he has led. He is passionate about advancing the life sciences industry and is known for his ability to navigate complex regulatory environments. In addition to his executive roles, he has served on boards and played a pivotal role in IPOs, showcasing his deep understanding of business dynamics in the pharmaceutical sector.
Michael Kallelis
Work Experience
Chief Executive Officer at
Mikart, LLC
August 2018 - Present
Vice President, Business Development at
KMC Systems Inc
July 2013 - August 2018
General Manager, Global Commercial Integrations & Head of Sales at Xcellerex ( a GE company) at
GE HealthCare
December 2009 - June 2013
General Manager, Global Commercial Operations at
Microlytic North America, Inc.
November 2008 - January 2010
President at
Exiqon
January 2006 - October 2008
Vice President, CMC at
Archemix
January 2005 - January 2006
COO & EVP at
Avecia Biotechnology Inc
January 1996 - January 2004
COO at
Boston Biosystems Inc.
January 1996 - January 1999
Michael Kallelis
Education
Salem State University, Bachelor's Degree
Frequently Asked Questions about Michael Kallelis
What is Michael Kallelis email address?
Michael Kallelis's primary email address is *********@mikart.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Michael Kallelis work for?
Michael Kallelis is a Chief Executive Officer at Mikart, LLC, a company specializing in Biological products, except diagnostic.
Where Michael Kallelis graduated from?
Michael Kallelis holds a degree in Biology & Chemistry from Salem State University.
How can I directly contact Michael Kallelis?
To contact Michael Kallelis directly, you can use the email address *********@mikart.com. Complete contact information is available upon registration with Muraena.
Who is Michael Kallelis?
Michael Kallelis is an accomplished Chief Executive Officer with a robust background in biochemistry and biotechnology, specializing in growth strategies for various market segments including drug development and diagnostics. With over 25 years of experience, he has successfully led organizations from start-ups to Fortune 6 companies, demonstrating a strong ability to manage and motivate cross-functional teams towards achieving common business goals. His expertise extends to mergers and acquisitions, sales, marketing, and operations, with a proven track record of increasing revenues and operational efficiencies. Michael's leadership is characterized by his strategic vision and hands-on approach, which has resulted in significant growth and innovation within the companies he has led. He is passionate about advancing the life sciences industry and is known for his ability to navigate complex regulatory environments. In addition to his executive roles, he has served on boards and played a pivotal role in IPOs, showcasing his deep understanding of business dynamics in the pharmaceutical sector.
Michael`s contact details
*********@mikart.com
*********@kmcsystems.com
Colleagues
Vice President, Quality and Regulatory
Vice President Marketing
Chief Financial Officer
Vice-President - Finance / CFO
Vice President Operations
VP, Product Development